benzyl N-[(2S,5S,11bR)-5-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamoyl]-3-oxo-1,2,5,6,11,11b-hexahydroindolizino[8,7-b]indol-2-yl]carbamate | 305322-47-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: benzyl N-[(2S,5S,11bR)-5-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamoyl]-3-oxo-1,2,5,6,11,11b-hexahydroindolizino[8,7-b]indol-2-yl]carbamate
• CAS: 305322-47-8
• 化学式: C₃₂H₃₁N₅O₅
• 分子量: 565.629
• InChiKey: USFVHFFEUZVHCE-RAVGUYNFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  42
• 可旋转键数：
  9
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  147
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  benzyl N-[(2S,5S,11bR)-5-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamoyl]-3-oxo-1,2,5,6,11,11b-hexahydroindolizino[8,7-b]indol-2-yl]carbamate 在 palladium on activated charcoal TEA 、 氢气 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 20.0 ℃ 、206.84 kPa 条件下， 反应 5.0h， 生成 (2S,5S,11bR,1'R)-2-[(N^α-(tert-butoxycarbonyl)-L-tryptophyl)amino]-5-[(1'-carbamoyl-2'-phenyl)ethyl]carbamoyl-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole
  参考文献：
  名称：

  Conformationally Constrained CCK4 Analogues Incorporating IBTM and BTD β-Turn Mimetics

  摘要：

  To test whether a turnlike arrangement is involved in the bioactive conformation of CCK4 analogues upon CCK1 receptor recognition, we describe the preparation of two series of CCK4 derivatives, in which the central dipeptide Met-Asp has been replaced by recognized beta-turn mimetics (2S,5S,11bR)- and (2R,5R,11bS)-2-amino-5-carboxy-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole (IBTM) and beta-turn dipeptide, 2-oxo-7-thio-1-azabicyclo[4.3.0]nonane (BTD)}. The incorporation of the indolizinoindole IBTM type II beta-turn mimetic is preferred over its type II' counterpart for efficient CCK1 receptor recognition, while BTD derivatives were completely inactive. The structure-conformation-activity relationship study in the IBTM series has shown some essential requirement of these CCK4 derivatives to favorably interact with CCK1 receptors: (a) the adoption of turnlike conformations, (b) the presence of an 1-Phe residue and a C-terminal carboxamide moiety, and (c) the indole ring of the IBTM skeleton. Moreover, the existence of pi-pi interactions between the phenyl ring of D-Phe residues and the indole ring of IBTM framework is detrimental for binding affinity. A series of potent and selective CCK1 receptor antagonists, exemplified by compounds 8a and 8b, emerges among these IBTM-containing derivatives.

  DOI：

  10.1021/jm050689o
• 作为产物：
  描述：

  D-苯丙氨酸甲酯 在 TEA 、 氨 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 benzyl N-[(2S,5S,11bR)-5-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamoyl]-3-oxo-1,2,5,6,11,11b-hexahydroindolizino[8,7-b]indol-2-yl]carbamate
  参考文献：
  名称：

  beta-Turned二肽作为有效和选择性CCK（1）受体拮抗剂。

  摘要：

  为了提高我们对CCK（1）拮抗剂的生物活性构象的认识，我们先前曾描述过用（2S，5S，11bR）-2-氨基-3-氧六氢吲哚并[8,7- b] indole-5-carbox ylate（IBTM）骨架，一种探测的II'型β-转弯模拟物，导致了受限的类似物（2S，5S，11bR，1'S）-和（2S，5S，11bR，1'R）- 2-（苄氧羰基）氨基-5- [1'-苄基-2'-（羧基）乙基]氨基甲酰基-3-氧代-2,3,5,6,11,11b-六氢-1H-吲哚并[8， 7-b]吲哚，1a，b，显示出对CCK（1）受体的高结合亲和力和选择性。在这份报告中，我们描述了化合物1的新类似物的合成和结合概况，旨在探索C末端残基的重要性以及受体结合亲和力和选择性的β转角类型的重要性。结构亲和关系的研究表明，C末端的游离羧酸和Phe和betaHph残基的S构型有利于CCK（1）受体识别。而且，该受体亚型的选择性

  DOI：

  10.1021/jm000959x

文献信息

• Conformationally Constrained CCK4 Analogues Incorporating IBTM and BTD β-Turn Mimetics
  作者：Mercedes Martín-Martínez、Natalia De la Figuera、Miriam LaTorre、M. Teresa García-López、Edurne Cenarruzabeitia、Joaquín Del Río、Rosario González-Muñiz

  DOI：10.1021/jm050689o

  日期：2005.12.1

  To test whether a turnlike arrangement is involved in the bioactive conformation of CCK4 analogues upon CCK1 receptor recognition, we describe the preparation of two series of CCK4 derivatives, in which the central dipeptide Met-Asp has been replaced by recognized beta-turn mimetics (2S,5S,11bR)- and (2R,5R,11bS)-2-amino-5-carboxy-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole (IBTM) and beta-turn dipeptide, 2-oxo-7-thio-1-azabicyclo[4.3.0]nonane (BTD)}. The incorporation of the indolizinoindole IBTM type II beta-turn mimetic is preferred over its type II' counterpart for efficient CCK1 receptor recognition, while BTD derivatives were completely inactive. The structure-conformation-activity relationship study in the IBTM series has shown some essential requirement of these CCK4 derivatives to favorably interact with CCK1 receptors: (a) the adoption of turnlike conformations, (b) the presence of an 1-Phe residue and a C-terminal carboxamide moiety, and (c) the indole ring of the IBTM skeleton. Moreover, the existence of pi-pi interactions between the phenyl ring of D-Phe residues and the indole ring of IBTM framework is detrimental for binding affinity. A series of potent and selective CCK1 receptor antagonists, exemplified by compounds 8a and 8b, emerges among these IBTM-containing derivatives.
• β-Turned Dipeptoids as Potent and Selective CCK₁ Receptor Antagonists
  作者：Mercedes Martín-Martínez、Natalia De la Figuera、Miriam Latorre、Rosario Herranz、M. Teresa García-López、Edurne Cenarruzabeitia、Joaquín Del Río、Rosario González-Muñiz

  DOI：10.1021/jm000959x

  日期：2000.10.1

  approximately 6-fold higher CCK(1) selectivity than analogue 16a, with the type II mimetic. From these results, we propose that the presence of a beta-turn-like conformation within the peptide backbone of dipeptoids could contribute to their bioactive conformation at the CCK(1) receptor subtype. Concerning functional activity, compounds 15a and 16a behave as CCK(1) receptor antagonists.

  为了提高我们对CCK（1）拮抗剂的生物活性构象的认识，我们先前曾描述过用（2S，5S，11bR）-2-氨基-3-氧六氢吲哚并[8,7- b] indole-5-carbox ylate（IBTM）骨架，一种探测的II'型β-转弯模拟物，导致了受限的类似物（2S，5S，11bR，1'S）-和（2S，5S，11bR，1'R）- 2-（苄氧羰基）氨基-5- [1'-苄基-2'-（羧基）乙基]氨基甲酰基-3-氧代-2,3,5,6,11,11b-六氢-1H-吲哚并[8， 7-b]吲哚，1a，b，显示出对CCK（1）受体的高结合亲和力和选择性。在这份报告中，我们描述了化合物1的新类似物的合成和结合概况，旨在探索C末端残基的重要性以及受体结合亲和力和选择性的β转角类型的重要性。结构亲和关系的研究表明，C末端的游离羧酸和Phe和betaHph残基的S构型有利于CCK（1）受体识别。而且，该受体亚型的选择性